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Abstract
Background: Filaggrin null mutations result in impaired skin barrier functions, increase the risk of early onset atopic
dermatitis and lead to a more severe and chronic disease. We aimed to characterize the clinical presentation and course of
atopic dermatitis associated with filaggrin mutations within the first 7 years of life.
Method: The COPSAC cohort is a prospective, clinical birth cohort study of 411 children born to mothers with a history of
asthma followed during their first 7 years of life with scheduled visits every 6 months, as well as visits for acute
exacerbations of dermatitis. Atopic dermatitis was defined in accordance with international guidelines and described at
every visit using 35 predefined localizations and 10 different characteristics.
Results: A total of 170 (43%) of 397 Caucasian children developed atopic dermatitis. The R501X and/or 2282del4 filaggrin
null mutations were present in 26 (15%) of children with atopic dermatitis and were primarily associated with predilection
to exposed skin areas (especially the cheeks and back of the hands) and an up-regulation of both acute and chronic
dermatitis. Furthermore, we found the filaggrin mutations to be associated with a higher number of unscheduled visits (3.6
vs. 2.7; p = 0.04) and more severe (moderate-severe SCORAD 44% vs. 31%; p = 0.14), and widespread dermatitis (10% vs. 6%
of the body area, p,0.001) with an earlier age at onset (246 vs. 473 days, p,0.0001) compared to wild-type.
Conclusion: In children, filaggrin mutations seem to define a specific endotype of atopic dermatitis primarily characterized
by predilection to exposed areas of the body, in particular hands and cheeks, and an up-regulation in both acute and
chronic morphological markers. Secondary, this endotype is characterized by an early onset of dermatitis and a more severe
course, with more generalized dermatitis resulting in more frequent medical consultations.
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Introduction
Approximately 10% of the general population carry at least one
null mutation in the filaggrin gene (FLG) [1]. Normal gene
expression results in intracellular filaggrin proteins which aggre-
gate keratin filaments, leading to keratinocyte compaction and
formation of the stratum corneum. Also, filaggrin expression is
crucial for loading of lamellar body contents, uniform extracellular
distribution of secreted organelle contents, and correct lamellar
bilayer architecture; key features in upholding the function of the
two compartment cornified envelope that prevents transepidermal
water loss and penetration of micro-organisms, chemicals and
allergens [2,3]. Heterozygous, and in particular homozygous or
compound heterozygous carriers of FLG null variants, experience
dry, scaly and fissured skin more often that non-mutation carriers
[4,5] and recent in vivo measurements of the stratum corneum in
patients with AD also found lower levels of natural moisturizing
factor among FLG deficient patients [6,7]. Furthermore, FLG
mutations are major predisposing factors for atopic dermatitis
(AD) [1,8–11] and are associated with early onset of AD,
persistence of AD into adulthood and asthma and allergic
sensitization [8,9,12–14]. Mutations seem to predict dose-de-
pendent alterations in epidermal permeability barrier function and
in accordance with this, homozygous carriers typically develop
ichtyoisis vulgaris and/or AD very early in life, whereas
heterozygous carriers may experience a milder course or no
symptoms at all [3,15,16].
Phenotyping based on FLG null mutations might represent
a novel endotype with known underlying molecular causes and,
presumably, distinct clinical features. Endotyping of AD is
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important for segmentation of patients and future investigations of
individualized treatment possibilities. Phenotypical characteriza-
tion based on prospective data collection has not yet been reported
for the FLG mutations. We meticulously characterized the pattern
of AD in the Copenhagen Prospective Birth Cohort during the
first 7 years of life and performed stratification by FLG mutation
status.
Materials and Methods
Ethics Statement
The Copenhagen Study on Asthma in Childhood (COPSAC)
was conducted in accordance with the guiding principles of the
Declaration of Helsinki, approved by the Ethics Committee for
Copenhagen (KF 01-289/96) and The Danish Data Protection
Agency (2002-41-2434). Data validity was assured by compliance
with ‘‘Good Clinical Practice’’ (GCP) guidelines and quality
control procedures. Data were collected on-line and locked after
external monitoring and an audit trail was run routinely. Informed
written consent was obtained from all parents.
Participants
The Copenhagen Study on Asthma in Childhood (COPSAC) is
a prospective, clinical, birth cohort study including 411 children
born to mothers with asthma. The children were enrolled at one
month of age and visited the clinical research unit at scheduled
visits every six months as well as for any acute skin symptoms. The
main recruiting area of the cohort was greater Copenhagen,
Denmark and all children were born between August 1998 and
December 2001. The study was previously detailed [17–19]. In
this study, we included data from Caucasians only, i.e. 397 of 411
enrolled children. Among these, 172 (43%) were diagnosed with
AD before age 7 years. In two cases, information about FLG
mutation status and registration of dermatitis were missing, leaving
170 children for analysis. Two homozygous/compound heterozy-
gous children were grouped with the heterozygous children. Skin
examinations, diagnoses and treatment of dermatitis were handled
by medical doctors employed for this purpose in the clinical
research unit.
Risk Assessments
AD was stratified by FLG mutation status and the groups were
analyzed for differences during the first 7 years of life. AD was
defined based on the criteria of Hanifin and Rajka [20]. FLG
genotyping was performed for R501X and 2282del4 mutations
using TaqMan-based allelic discrimination assay and fluorescently
labelled PCR (Applied Biosystems 3100, 3730 and 7700 sequence
detection system, Foster City, CA, USA) [8]. Individuals
designated as ‘‘wild type’’ were therefore patients not carrying
these two common mutations, but carrier status of other, rare FLG
mutations, cannot be excluded for this group.
At each visit, the following observations were registered:
N Anatomical localization of dermatitis lesions were divided
into 35 predefined areas: abdomen, ankle (back), ankle (front),
back (lower), back (upper), cheek, chest, chin, ear, elbow
(back), elbow (front), eye area, foot (back), foot (sole), forearm
(back), forearm (front), forehead, hand (back), hand (palm),
knee (back), knee (front), lower leg (back), lower leg (front),
nappy region, neck (back), neck (front), nose, perioral, scalp,
upper arm (back), upper arm (front), upper leg (back), upper
leg (front), wrist (back) and wrist (front).
N Morphology of the single dermatitis lesion was based on the
following characteristics: area (in percent of the total body
surface area), erythema, lichenification, crusts, dryness,
vesicles, squamation, fissures, edema and excoriations (grad-
uated from 0 (none) to 3 (severe)).
N Severity of the dermatitis episode was assessed using the
Scoring Atopic Dermatitis index (SCORAD) [21].
Statistical Analyses
Associations between FLG mutation status (null vs. wild type)
and different variables were investigated using the following
analyses: Cox proportional-hazards regression (PROC PHREG)
(AD diagnosis), chi-square test (PROC FREQ) (frequency of
localizations), log-rank test (PROC LIFETEST) (age at onset of
AD), the non-parametric Wilcoxon Rank-Sum Test (PROC
NPAR1WAY) (number of visits in the clinical research unit),
and GEE-model (PROC GENMOD) (SCORAD, total area of the
body involved pr visit). All analyses were done in SAS version 9.1
(SAS Institute Inc, Cary, NC). The overall significance level used
was 0.05.
A multivariate approach was employed to detect clinical
patterns related to FLG null mutation status. We applied Partial
Least Squares Discriminant Analysis (PLSDA) [22] to describe the
anatomical location of dermatitis and Principal Component
Analysis (PCA) to describe dermatitis morphology, in both cases
with the aim of exploring differences in relation to FLG mutation
status.
1) Anatomical location. The number of registrations (con-
tinuous) was used as predictors. The pattern of the 35 different
regions was visualized including how they were associated with the
FLG genotype both individually and compared to the other
regions. The component consists of a score matrix with samples
distribution and a loading matrix where the relation between the
predictors (regions) was created and displayed.
2) Dermatitis morphology. For each region (n= 35) and
each FLG mutation type (wild type and null), the morphology
parameters (erythema, lichenification, crusts, dryness, vesicles,
squamation, fissures, edema and excoriations) were represented by
a weighted average across all registrations taking the different
registration frequencies into account. This resulted in a 70 by 9
matrix. PCA with two components and varimax rotation was then
conducted on this matrix. Here the score plot displays the similarity
between regions in connection with FLG mutation status. The
loading plot unravels the correlation structure between the
morphology parameters [23].
PLSDA and PCA were conducted using the PLStoolbox ver.
6.0.1 (Eigenvector Inc, Manson, Washington, USA.). In addition
in-house algorithms were used for visualization. All analysis where
conducted in MatlabH R2010b version 7.11.0.584.
Additional methodological details are given in ‘‘Supporting
Information S1: Materials and methods’’.
Results
Twenty six (15.3%) of 170 AD children and 15 (7.1%) of 212
non-AD children were FLG null mutation carriers (HR 2.23, 95%
CI 1.47–3.39, p = 0.0002). The lifetime prevalence of AD was
63% in children with the FLG null genotype and 43% in children
with the wild type.
Anatomical Dermatitis Localizations
The anatomical localization of dermatitis stratified by FLG
mutation status (affected per visit) is presented in figure 1. Here,
the 35 predefined areas were grouped into 11 areas (for details,
please see Table S1). The analysis showed that involvement of the
Endotyping Atopic Dermatitis by Filaggrin
PLOS ONE | www.plosone.org 2 November 2012 | Volume 7 | Issue 11 | e48678
palm and back of the hands, the flexor and extensor extremities,
the feet and the cheeks was statistically significant associated with
the FLG null genotype (p values between ,0.0001 and 0.002).
PLSDA analysis of the original 35 regions confirmed this positive
association, with a tendency towards higher number of different
localizations for the FLG null children, as all loading values were
positive in the first component, mainly driven by affection of the
cheeks and the back of the hands, No differences were seen for the
flexural area (p,0.01) (Figure S1). Figure 2 summarizes the
localizations that were more often affected in FLG null children
(red and blue areas), with the red areas illustrating the localizations
significantly selected by the PLSDA (cheeks and back of the hand).
To investigate whether the anatomical localizations associated
with the FLG null genotype were age dependent, further
stratification was performed (0–3 and 3–7 years). However, we
found no change in predilection of dermatitis (data not shown).
Morphology
Firstly, three regions were excluded from the analyses due to
a low number of registrations (eye area, plantar part of the foot,
and the nose). Secondly, two components, describing 58% of the
total variation, were extracted by PCA (component 1 and 2). The
PCA loading plot separated chronic signs of dermatitis such as
fissures, lichenification and crusting (x-axis) from acute signs of
dermatitis such as oedema and erythema (y-axis). Characteristics
closely positioned are correlated and therefore exhibited similar
pattern, e.g. high loadings for erythema track with high loadings
for edema and vesicles etc. (Figure 3a). It is important to notice
that the PCA does not aim at separating different markers
(unsupervised), and that the chronic and acute components simply
appear, because the main variation turns out to be reflected by
these two patterns. Thirdly, the information obtained in the PCA
loading plot, was combined with information about the morphol-
Figure 1. Frequency of skin localizations in respect to filaggrin status. Frequency of localizations in relation to the number of visits at the
clinical research unit, 0–7 years, grouped and stratified by FLG status. Numbers above the bars indicate the p values.
doi:10.1371/journal.pone.0048678.g001
Figure 2. Summary of skin localizations in respect to filaggrin
status. The figure summarizes the localizations more often affected in
children with FLG null mutations compared to wild type children (red
and blue areas), with red areas illustrating the localizations specifically
selected by PLSDA as driving sites.
doi:10.1371/journal.pone.0048678.g002
Endotyping Atopic Dermatitis by Filaggrin
PLOS ONE | www.plosone.org 3 November 2012 | Volume 7 | Issue 11 | e48678
ogy at the separate skin localizations via a score plot (figure 3b). At
the score plot, the positions in truncated principal component
space of the dermatitis lesions are shown. The figure describes the
distribution of the skin regions, so that closely positioned points
exhibit a similar pattern with respect to the morphology
parameters reflected in the loading plot (figure 3a). Each region
is shown as two points (blue and red circles representing FLG wild
type and FLG null, respectively) connected with an arrow from the
FLG wild genotype to the FLG null genotype. To get an idea of
how these two plots are interpreted, consider the skin region
Extremities flex as an example. The location of FLG null is high in
component 2 compared to FLG wild type (figure 3b). This means
that this skin region exhibits a more severe dermatitis for FLG null
with respect to the acute inflammatory markers, that span this
component (component 2– figure 3a). On the other hand, there
seems to be no difference between the severities of the chronic
inflammatory markers between the two genotypes reflected by the
position on component 1. Likewise, it is registered that Wrist back,
in terms of chronic inflammatory markers, is one of the skin
regions with the most severe dermatitis with slightly higher severity
for the FLG null type compared to the FLG wild type, but with no
difference between the severities of acute markers (component 2).
Figure 3b showed that the majority of arrows pointed up or
towards the right, i.e. pointing in the same directions as the acute
and chronic markers at the loading plot, which means that
a general up-regulation of both acute and chronic markers was
observed in FLG null children when compared to wild type
children. Interpretation of single region differences between the
two groups, revealed a pattern with certain regions up-regulated in
acute markers (extensor areas, extremities flex areas, truncus, hand
(palm/back)) and in chronic markers (feet area, wrist (front/back),
hand back). These two figures (3a and 3b), serve as a comprehen-
sive overview comparing the severity pattern of nine dermatitis
markers for 15 different skin regions between two FLG genotypes.
At figure 3b the localizations are grouped according to Table S1
except for the two groups Hand area front and -back which are kept
as (six) individual regions. For the plot based on the original 32
skin regions, see Figure S2.
Severity
The skin was examined at 905 separate visits of which 276
(30.5%) were unscheduled visits for acute skin symptoms. Children
with the FLG null mutations had more unscheduled visits than wild
type children (mean 3.6 vs. 2.7 visits, p = 0.036) and FLG null
children presented a higher SCORAD score than wild type
children, albeit not statistically significant (44% vs. 31% with
moderate-severe SCORAD, p=0.14). Similar, non-significant
trends were found in SCORAD values at unscheduled and
scheduled visits separately (results not shown).
FLG null carriers had earlier onset of dermatitis (median age
128 vs. age 299 days, p,0.0001) and a more widespread
dermatitis at each visit compared to wild type children (median
10% vs. 6% of the body, p,0.001). A similar difference was seen
at both scheduled and unscheduled visits (results not shown).
Discussion
Main Finding
Primarily, this study showed that in our cohort of at-risk
children, the FLG null driven AD endotype is characterized by
dermatitis at anatomical localizations that tend to be exposed to
drying conditions (e.g. wind, cold, sun and radiations from indoor
heating), especially the back of the hands and the cheeks (figure 2)
and with dermatitis lesions characterized by an up-regulation in
both acute and chronic markers when compared to wild type
children. Moreover, this endotype had a higher frequency of acute
dermatitis episodes, as illustrated by more unscheduled visits to our
clinic, and also a more generalized, and severe dermatitis (higher
SCORAD) when compared to FLG wild type children with AD,
although the differences in severity were marginal.
Strengths and Limitations
The COPSAC cohort consists of prospective collection of data
during the first 7 years of life. The diagnosis, detailed phenotype
and management of skin lesions have been controlled solely by the
clinical research unit physicians from standard operating proce-
dures and treatment algorithms, and not by the general
practitioner or others. Hence, the specificity of the AD diagnosis
is high and the risk of misclassification is expected to be low. This
is of particular importance in the clinical evaluation of AD where
inter-observer variation may be a problem [24]. The children were
followed every 6 months and were also seen in case of acute flare-
up of dermatitis. Such prospective data collection reduces the risk
of recall bias.
Our study is limited by all children being of Caucasian descent
and it is possible that FLG mutations may not exert the same effect
in other races. Furthermore, they are at-risk children with mothers
suffering from asthma, thereby risking interaction with asthma
genetics. Therefore, our results need replication in an unselected
population.
Because of the project protocol, with the children being followed
closely by trained physicians when having acute flare-ups, these
children are more likely to receive better treatment than the
general population. This optimized care is a potential confounder,
which may dilute the differences between FLG null and wild type
children with AD. However, this would support the genuine
difference between the two groups regarding the anatomical
localization and morphological presentation of their dermatitis.
Despite our modest sample size we are the first to report
a prospective registration of the dermatitis morphology and
localization in AD patients stratified by FLG mutations. Since we
find differences between the two strata, study size did not cause
a type 2 error.
We used classic bar charts to illustrate our main findings and
confirmed them by multivariate pattern analysis, i.e. PLSDA and
PCA. This approach facilitates the handling of many variables in
the same analysis, which is especially important for complex
phenotypic data. Multivariate pattern analysis makes it possible to
study the systematic variation, while filtering out uncorrelated
random variation and hence observe patterns not otherwise
recognized by traditional univariate statistical analysis. We were
able to extract plausible acute and chronic components from the
morphological data and characterize different skin regions. In this
way, we use a data analytical approach more in line with the
clinicians approach to clinical problems which is more often
characterized by pattern recognition rather than any single
markers.
Interpretation
AD has traditionally been classified as acute vs. chronic,
intrinsic vs. extrinsic, associated with ichthyosis vulgaris, based on
morphology (nummular, atopic prurigo, lichen planus-like, pity-
riasis alba) or based on localization (hand, juvenile plantar and
palmar, eyelid, cheilitis, nipple, periorificial). However, none of
these classifications seem to be satisfying, because patients often
experience dynamic changes between the suggested categories and
with affection of different sites [25]. Our data suggest that FLG null
mutations, the cause of ichthyosis vulgaris, are associated with
Endotyping Atopic Dermatitis by Filaggrin
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dermatitis at ‘‘exposed areas’’, especially the cheeks and the back
of the hands, but also the feet and extensor areas. These sites are
typically exposed to drying and irritant factors such as water, sun,
wind, child’s play, changes in temperatures and radiation from
indoor heating. It is likely that these factors may act as local
triggers, resulting in further dry skin than dictated by the inherited
skin constitution, and then dermatitis. In contrast, dermatitis in
wild type children was not located on these rather exposed sites.
Figure 3. Morphology of the individual skin localizations. A: PCA loading plot for the first two components. Morphological characteristics
such as fissures, lichenification and crust were found correlated as seen by the grouping at the x-axis (component 1, chronic markers), whereas
edema, erythema and vesicles were grouped at the y-axis (component 2, acute markers). B: PCA score plot showing the morphology of the individual
localizations. Each region is shown as two points (‘‘blue circles’’: FLG wild type, ‘‘red circles’’: FLG null) connected with an arrow from FLG wild type to
FLG null. E.g. hand (back) obtained higher values with respect to chronically inflammatory markers than e.g. forearm (front). A general up-regulation
of both acute and chronic markers was observed for FLG null children across almost all regions.
doi:10.1371/journal.pone.0048678.g003
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Supporting this interpretation, FLG deficient flaky tail mice bred in
cages with contact to the environment, had a higher level of
dermatitis and skin inflammation when compared to mice bred in
cages with no environmental contact [26]. Other mechanisms,
rather than primary barrier abnormality, might be responsible for
the FLG wild type children’s dermatitis. This could be changes in
immunomodulatory factors, heat or bacterial growth.
Our study’s suggested association between FLG null carrier
status and hand dermatitis, is in line with a recent general
population study, showing that the FLG null genotype significantly
increased the risk of hand dermatitis in individuals with AD and
that it was associated with early onset (before age 6) and
persistence into adulthood [27]. Furthermore, the clinical obser-
vation was recently made, that adult patients with the FLG null
genotype had a distinct phenotype of hand dermatitis character-
ized by fissured eruptions on the back of the hands and wrists with
only sparse involvement of the palmar aspects, similar to the
clinical description of hand dermatitis among atopic individuals
previously described by other groups [28,29]. It is interesting that
we could partly confirm this finding in our cohort of children, as
FLG null carriers mainly had chronic markers of dermatitis on the
back of their hands, whereas acute markers were upregulated in
the palms as well as the back of the hands. Hence, the ‘‘dorsal
hand eczema’’ as seen in patients with AD might indeed be
associated with the FLG null genotype.
As a secondary finding we showed that FLG null children had
more severe dermatitis, characterized by a higher number of visits
in the clinical research unit, a more generalized dermatitis and
a non-significant trend of higher SCORAD value. Also, FLG null
mutations were associated with an earlier onset of disease. These
observations are in agreement with previous cross-sectional reports
[12,13,25,30] and suggest that FLG genotyping should be
considered in the initial diagnostic work of patients suspected
with AD and that it may be useful for classification.
Conclusion
In this study of at-risk children with AD, we find that the FLG
null defines an endotype characterized by dermatitis with a pre-
dilection site at exposed areas of the body, in particular hands and
cheeks, and an up-regulation in both acute and chronic
morphological markers. Furthermore this endotype is character-
ized by an early onset of dermatitis and a more severe course with
more generalized dermatitis resulting in more frequent medical
consultations. These findings will hopefully help us segmenting AD
patients and promise individualized treatment in the future, as well
as improved disease prediction and research into novel preventive
approaches. This is the first study reporting a prospectively
characterizing of the morphology and localization of childhood
dermatitis and stratifying it by FLG mutation status. However,
future studies including replication in an unselected population are
needed to confirm our findings.
Supporting Information
Figure S1 Figure S1A (PLSDA score plot) and Figure S1B
(PLSDA loading plot): Skin localizations. PLSDA score- (A)
and loading (B) plot for having dermatitis on a given localization in
relation to number of visits in the clinic. Ellipsoids are centered at
population mean with half axis corresponding to the standard
deviation and under normality assumption hence cover ,50% of
data. Red and blue represents FLG wild type and null mutation
carriers, respectively.
(TIF)
Figure S2 Morphology of the individual skin localiza-
tions. Original PCA score plot showing the morphology of the
individual localizations. Each region is shown as two points (‘‘blue
circles’’: FLG wild type, ‘‘red circles’’: FLG null) connected with an
arrow from FLG wild type to FLG null. E.g. hand (back) obtained
higher values with respect to chronically inflammatory markers
than e.g. forearm (front). A general up-regulation of both acute
and chronic markers was observed for FLG null children.
(TIF)
Table S1 Grouping the 35 predefined localizations into 11
groups.
(DOC)
Supporting Information S1 ‘‘Materials and methods’’ E-
laborated statistical explanation for the multivariate analysis
PLSDA.
(DOC)
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